Your browser doesn't support javascript.
loading
In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Foleno, Barbara D; Abbanat, Darren; Goldschmidt, Raul M; Flamm, Robert K; Paget, Steve D; Webb, Glenda C; Wira, Ellyn; Macielag, Mark J; Bush, Karen.
Afiliação
  • Foleno BD; Johnson and Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ 08869, USA. bfoleno@prdus.jnj.com
Antimicrob Agents Chemother ; 51(1): 361-5, 2007 Jan.
Article em En | MEDLINE | ID: mdl-17101672
ABSTRACT
RWJ-416457, an investigational pyrrolopyrazolyl-substituted oxazolidinone, inhibited the growth of linezolid-susceptible staphylococci, enterococci, and streptococci at concentrations of < or =4 microg/ml, generally exhibiting two- to fourfold-greater potency than that of linezolid. Time-kill studies demonstrated bacteriostatic effects for both RWJ-416457 and linezolid.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Oxazolidinonas / Antibacterianos Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Oxazolidinonas / Antibacterianos Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2007 Tipo de documento: Article País de afiliação: Estados Unidos